For decades, the ECG has been a fundamental yet relatively limited diagnostic tool in cardiovascular medicine. However, AI-enabled technologies are shifting this paradigm by extracting layers of hidden biological signals that go well beyond visual interpretation. This article explores how healthcare systems can thoughtfully implement ECG-AI to catch silent heart disease earlier and transform routine data into actionable care decisions.
Turning ECG Data into Actionable Insight with AI
Related Articles
New Project Trains AI on a Hard-to-Diagnose Cardiac Issue
Health Leaders: A start-up from the Mayo Clinic orbit is partnering with Pfizer to develop an AI-enhanced ECG that can detect cardiac amyloidosis, a progressive disease that's difficult to diagnose…{post_date: F d, Y}
Pfizer partners with healthtech company on AI-powered cardiovascular disease detection
Becker's Hospital Review: Pharmaceutical giant Pfizer has partnered with digital health company Anumana, a company founded in 2021 in collaboration with the Mayo Clinic Platform, to develop an artificial intelligence…{post_date: F d, Y}
AI specialists ink deal with Pfizer to target cardiac amyloidosis
Cardiovascular Business: Anumana, a Massachusetts-based healthcare technology company focused on artificial intelligence (AI), has announced a new multi-year deal with Pfizer focused on improving the identification and diagnosis of cardiac…{post_date: F d, Y}
FDA grants Breakthrough Device Designation to pulmonary hypertension early detection AI
Pharma File: Anumana has announced the FDA had granted breakthrough Device Designation to its AI-enhanced ECG-based Pulmonary Hypertension (PH) Early Detection Algorithm. Breakthrough Device Designations recognise novel innovations demonstrating potential…{post_date: F d, Y}